COMP <GO>
INSP vs KMTS // OPERATING MARGIN
Inspire Medical Systems Inc. (NYSE) VS. Kestra Medical Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: INSP 8
— KMTS 2
▲ OPERATING MARGIN LEADER: INSP
LAST: $71.18 (+0.30%) • MKT CAP: $2.06B
operating-margins
5.60%
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSP VS. KMTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSP | KMTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.40% | 51.40% | +34.00 | INSP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | -35.00% | +41.00 | INSP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.81% | -6.40% | +10.21 | INSP | /fcf-yield <GO> |
| Operating Margin ACTIVE | 5.60% | -60.00% | +65.60 | INSP | /operating-margins <GO> |
| Net Profit Margin | 15.90% | -60.00% | +75.90 | INSP | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 59.00% | -45.40 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.40 | 9.65 | +1.75 | INSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | INSP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.5 | 60.8 | -7.30 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.06B | $1.82B | $234.7M | INSP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSP REV | KMTS REV | INSP GROSS % | KMTS GROSS % | INSP FCF | KMTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $912.0M | $95.1M | 85.4% | 51.4% | $78.5M | -$116.6M |
| FY 2024 | $802.8M | $59.8M | 84.7% | 40.5% | $91.1M | -$100.5M |
| FY 2023 | $624.8M | $27.8M | — | — | $24.7M | -$72.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSP // BETA —
KMTS // BETA —